AL 3264

Known as: AL-3264 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-1995
01219891995

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The administration of propranolol can provoke bronchoconstriction in asthmatic patients. We hypothesized that such… (More)
Is this relevant?
1995
1995
To clarify the antiallergic effect and antiallergic mechanism of AL-3264 (N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6… (More)
Is this relevant?
1994
1994
The effects of AL-3264, which exhibits a 5-lipoxygenase (5-LO) inhibiting property by blocking histamine H1-receptors and… (More)
Is this relevant?
1993
1993
Antiallergic effects of AL-3264 (N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide, CAS 118420-47-6… (More)
Is this relevant?
1993
1993
In order to examine the penetration of N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyrid yl) acrylamide (AL-3264… (More)
Is this relevant?
1989
1989
A new series of 3-(3-pyridyl)acrylamides 16, 17, 19, and 26, and 5-(3-pyridyl)-2,4-pentadienamides 20-25 were prepared and… (More)
Is this relevant?